Acyclovir for the prevention of recurrent herpes simplex virus eye disease

New England Journal of Medicine

Volumn 339, Issue 5, 1998, Pages 300-306

  Wilhelmus, Kirk R ^b   Beck, Roy W ^a   Moke, Pamela S ^b   Dawson, Chandler R ^b   Barron, Bruce A ^b   Jones, Dan B ^b   Kaufman, Herbert E ^b   Kurinij, Natalie ^b   Stulting, R Doyle ^b   Sugar, Joel ^b   Cohen, Elisabeth J ^b   Hyndiuk, Robert A ^b   Ashell, Penny A ^b  

^a JAEB CENTER FOR HEALTH RESEARCH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; PLACEBO;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; CORNEA DISEASE; DRUG EFFICACY; ERYTHEMA NODOSUM; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS; HUMAN; KERATITIS; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; TREATMENT OUTCOME; VIRUS INFECTION;

ACYCLOVIR; ANTIVIRAL AGENTS; BLEPHARITIS; CONJUNCTIVITIS; FEMALE; HUMANS; INCIDENCE; IRITIS; KERATITIS, HERPETIC; MALE; MIDDLE AGED; RECURRENCE; TREATMENT OUTCOME;

EID: 7344245411     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199807303390503     Document Type: Article

References (17)

1. Liesegang TJ, Melton LJ 3rd, Daly PJ, Ilstrup DM. Epidemiology of ocular herpes simplex: incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol 1989;107:1155-9.
2. Mertz GJ, Jones CC, Mills J, et al. Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection: a multicenter double-blind trial. JAMA 1988;260:201-6.
3. Mattison HR, Reichman RC, Benedetti J, et al. Double-blind, placebo-controlled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpes. Am J Med 1988;85:Suppl 2A:20-5.
4. Spruance SL, Hamill ML, Hoge WS, Davis LG, Mills J. Acyclovir prevents reactivation of herpes simplex labialis in skiers. JAMA 1988;260: 1597-9.
5. Rooney JF, Straus SE, Mannix ML, et al. Oral acyclovir to suppress frequently recurrent herpes labialis: a double-blind, placebo-controlled trial. Ann Intern Med 1993;118:268-72.
6. Blatt AN, Laycock KA, Brady RH, Traynor P, Krogstad DJ, Pepose JS. Prophylactic acyclovir effectively reduces herpes simplex virus type 1 reactivation after exposure of latently infected mice to ultraviolet B. Invest Ophthalmol Vis Sci 1993;34:3459-65.
7. Kaufman HE, Varnell ED, Centifanto-Fitzgerald YM, DeClereq E, Kissling GE. Oral antiviral drugs in experimental herpes simplex keratitis. Antimicrob Agents Chemother 1983;24:888-91.
8. Colin J, Robinet A, Malet F. Preventive treatment of herpetic keratitis with acyclovir tablets. J Fr Ophtalmol 1993;16:6-9. (In French.)
9. Simon AL, Pavan-Langston D. Long-term oral acyclovir therapy: effect on recurrent infectious herpes simplex keratitis in patients with and without grafts. Ophthalmology 1996;103:1399-405.
10. Rodriguez A, Power WJ, Neves RA, Foster CS. Recurrence rate of herpetic uveitis in patients on long-term oral acyclovir. Doc Ophthalmol 1995;90:331-40.
11. Manual of operations: Herpetic Eye Disease Study: prevention studies. Springfield, Va.: National Technical Information Service, August 1, 1994. (Accession #PB97-112999).
12. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983;70:659-63.
13. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
14. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34: 187-220.
15. Liesegang TJ. Epidemiology of ocular herpes simplex: natural history in Rochester, Minn, 1950 through 1982. Arch Ophthalmol 1989;107:1160-5.
16. Whitley RJ, Gnann JW Jr. Acyclovir: a decade later. N Engl J Med 1992;327:782-9. [Erratum, N Engl J Med 1993;328:671.]
17. The Herpetic Eye Disease Study Group. A controlled trial of oral acyclovir for the prevention of stromal keratitis or iritis in patients with herpes simplex virus epithelial keratitis. Arch Ophthalmol 1997;115:703-12. [Erratum, Arch Ophthalmol 1997;115:1196.]